{"name": "Trimeris",
 "permalink": "trimeris",
 "crunchbase_url": "http://www.crunchbase.com/company/trimeris",
 "homepage_url": "http://www.trimeris.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1993,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "919-806-4682",
 "description": "HIV Research",
 "created_at": "Fri Oct 09 12:14:57 UTC 2009",
 "updated_at": "Tue Jun 14 03:34:05 UTC 2011",
 "overview": "\u003Cp\u003EBased in Morrisville, North Carolina, Trimeris was founded in 1993 by leading researchers in the study of the human immunodeficiency virus (HIV). Their work in the early 1990s led to a breakthrough in the fight against AIDS \u00e2\u20ac\u201d an entirely new class of anti-HIV drugs called fusion inhibitors. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[106,
       110],
      "assets/images/resized/0006/2233/62233v1-max-150x150.jpg"],
     [[106,
       110],
      "assets/images/resized/0006/2233/62233v1-max-250x250.jpg"],
     [[106,
       110],
      "assets/images/resized/0006/2233/62233v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Chief Financial Officer",
    "person":
     {"first_name": "Andrew",
      "last_name": "Graham",
      "permalink": "andrew-graham",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 81000000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "http://online.wsj.com/article/BT-CO-20091002-709425.html",
   "source_description": "Arigene To Pay $81M For Trimeris In Tender Offer \u003ETRMS ",
   "acquired_year": 2009,
   "acquired_month": 10,
   "acquired_day": 2,
   "acquiring_company":
    {"name": "Arigene",
     "permalink": "arigene",
     "image": null}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2530 Meridian Parkway",
    "address2": "2nd Floor ",
    "zip_code": "27713",
    "city": "Durham",
    "state_code": "NC",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Updated: Synageva goes public in M\u0026A deal with troubled Trimeris\r\n",
    "stoned_year": 2011,
    "stoned_month": 6,
    "stoned_day": 13,
    "source_url": "http://www.fiercebiotech.com/story/synageva-snags-troubled-trimeris-all-stock-ma-deal/2011-06-13?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Updated: Synageva goes public in M\u0026A deal with troubled Trimeris",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Trimeris",
      "permalink": "trimeris"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        92],
       "assets/images/resized/0006/2234/62234v1-max-150x150.jpg"],
      [[250,
        154],
       "assets/images/resized/0006/2234/62234v1-max-250x250.jpg"],
      [[450,
        277],
       "assets/images/resized/0006/2234/62234v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}